News | SPECT-CT | October 18, 2022

Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine

Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine

October 18, 2022 —  Spectrum Dynamics announced its newest development in digital nuclear medicine imaging: the capability to image high energy isotopes using solid-state detector technology in a 3600-CZT based, wide-bore SPECT/CT configuration. This functionality is available in the new VERITON-CT 400 Series Digital SPECT/CT scanners, enabling total body, brain, heart and other imaging applications. 

“This truly represents a transformation in how we will image high energy isotopes: with the sensitivity benefits of digital detector technology, advanced reconstruction algorithms and total body coverage in 3D, both patients and clinicians will benefit from this innovation”, said Nathaniel Roth, VP Research and Development and Clinical Research, Spectrum Dynamics. 

The VERITON-CT 400 Series features Spectrum Dynamics’ radical design, with its 3600 ring-shaped gantry with 12 swiveling CZT detectors, that revolutionized nuclear medicine imaging industry in 2017. During the scan, the digital detectors automatically follow the patient’s body contour, providing exceptional proximity for increased sensitivity and better image quality. This design results in three times the volumetric sensitivity for routine 3D hybrid imaging without compromising patients comfort or department workflow. The scanner is available in 16-slice CT and 64-slice CT configuration enabling localization and attenuation correction for accurate quantification. 

“The new VERITON-CT 400 has proved to be advantageous for high-energy tracers. In our nuclear medicine community, the main challenge now is to personalize and adapt targeted treatments to each individual. This requires precise determination of the distribution of delivered doses within the body. The scanner has the potential to do so with high quantitative accuracy and fast scan times to be used for a routine application”, said Prof. Pierre-Yves Marie, MD, Ph.D., Head Department of Nuclear Medicine, University Hospital of Nancy, France. 

For more information: https://spectrum-dynamics.com/ 

Find more ASTRO22 content here


Related Content

Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | SNMMI

June 13, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians ...

Time June 13, 2024
arrow
News | PET-CT

June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 13, 2024
arrow
Subscribe Now